Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
168 USD | -0.41% |
|
+0.91% | +8.43% |
Jul. 12 | AbbVie Submits FDA, EMA Applications for Upadacitinib to Treat Giant Cell Arteritis | MT |
Jul. 12 | AbbVie Seeks U.S., Europe OK of Rinvoq in Giant Cell Arteritis | DJ |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.43% | 301B | |
+63.05% | 854B | |
+39.42% | 636B | |
-4.78% | 361B | |
+17.52% | 324B | |
+14.19% | 247B | |
+5.81% | 230B | |
+16.77% | 228B | |
+14.63% | 177B | |
+1.08% | 164B |
- Stock Market
- Equities
- ABBV Stock
- News AbbVie Inc.
- Transcript : AbbVie Inc. Presents at Bank of America Health Care Conference 2024, May-15-2024 10